Summit Securities Group’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-500
Closed -$10K 806
2024
Q2
$10K Hold
500
﹤0.01% 441
2024
Q1
$12K Sell
500
-500
-50% -$14.9K ﹤0.01% 338
2023
Q4
$36K Buy
+1,000
New +$38.5K ﹤0.01% 425

Other funds holding PRTA

Summit Securities Group's PRTA Position: Q3 2024 in Review

Summit Securities Group sold out of Prothena Corp (PRTA) in Q3 2024, closing a stake of 500 shares — an estimated $10K sold.

Summit Securities Group first reported a position in PRTA in Q4 2023 and held it in 3 quarters. The position peaked at $36K in Q4 2023. 164 funds tracked by Wall St. Rank hold PRTA as of Q3 2024.

  • Summit Securities Group reported no remaining Prothena Corp position as of Q3 2024 after selling out during the quarter.
  • Summit Securities Group sold 500 Prothena Corp shares in Q3 2024, an estimated $10K.
  • Summit Securities Group first reported a position in Prothena Corp in Q4 2023 and held it in 3 quarters.
  • Summit Securities Group's Prothena Corp position peaked at $36K in Q4 2023.
  • 164 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2024.

Based on Summit Securities Group's 13F filing for Q3 2024, filed 7 Nov 2024.